acute myeloid leukemia cells Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of

[1]  A. Fauser,et al.  Culture studies of human pluripotent hemopoietic progenitors , 1980, Blut.

[2]  J. Ritz,et al.  Comparative activities of rabbit complements of different ages using an in-vitro marrow purging model. , 1990, Leukemia research.

[3]  R. Bast,et al.  Autologous bone marrow transplantation for acute lymphoblastic leukemia. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. Vitetta,et al.  Redesigning nature's poisons to create anti-tumor reagents. , 1987, Science.

[5]  A I Goldman,et al.  Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. , 1987, The New England journal of medicine.

[6]  K. Anderson,et al.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.

[7]  M. Ogawa,et al.  Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors. , 1987, Blood.

[8]  J. Griffin.  The use of monoclonal antibodies in the characterization of myeloid leukemias. , 1987, Hematologic pathology.

[9]  J. Griffin,et al.  Clonogenic cells in acute myeloblastic leukemia. , 1986, Blood.

[10]  E. Ball,et al.  Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies. , 1986, Blood.

[11]  J. Ritz,et al.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells. , 1986, The Journal of clinical investigation.

[12]  O. Colvin,et al.  Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. , 1986, The New England journal of medicine.

[13]  J. Griffin,et al.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia. , 1985, The Journal of clinical investigation.

[14]  V. Raso,et al.  Carboxylic ionophores enhance the cytotoxic potency of ligand- and antibody-delivered ricin A chain , 1984, The Journal of experimental medicine.

[15]  D. Vallera,et al.  MONOCLONAL ANTIBODY‐TOXIN CONJUGATES REACTIVE AGAINST HUMAN T LYMPHOCYTES: A COMPARISON OF ANTIBODY LINKED TO INTACT RICIN TOXIN WITH ANTIBODY LINKED TO RICIN A CHAIN , 1984, Transplantation.

[16]  D. Neville,et al.  Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution. , 1982, The Journal of biological chemistry.

[17]  J. Ritz,et al.  Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. , 1982, Blood.

[18]  J. Ritz,et al.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells. , 1981, The Journal of clinical investigation.

[19]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[20]  F. Sieber,et al.  Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose‐concanavalin A , 1974, Journal of cellular physiology.

[21]  B. Pike,et al.  Human bone marrow colony growth in agar‐gel , 1970, Journal of cellular physiology.